Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 36 of PMV Pharmaceuticals, Inc.'s SEC filings and found 2 warrant series, 1 ATM program, 1 shelf registration, 1 S-1 registration and 1 completed offering on file for PMVP. The latest dilution event on file is an offering on Sep 2, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
BDTXBlack Diamond Therapeutics, Inc.
IMUXImmunic, Inc.
ANIXAnixa Biosciences, Inc.
KZIAKazia Therapeutics Limited American Depositary Shares
EQEquillium, Inc.
UNCYUnicycive Therapeutics, Inc.
ARMPArmata Pharmaceuticals, Inc.
ENGNenGene Holdings Inc.
OKUROnKure Therapeutics, Inc.
OTLKOutlook Therapeutics, Inc.
NKTXNkarta, Inc.
VYGRVoyager Therapeutics, Inc.
AVXLAnavex Life Sciences Corp.
HURATuHURA Biosciences, Inc.
PYPDPolyPid Ltd. Ordinary Shares